Dr Reddy’s Laboratories failed to cheer the market despite June quarter net profit doubling. Analysts see concern over the US business and pressure on operating performance as key drags. These concerns have prompted traders to build bearish bets on the stock. Chandan Taparia, derivative analyst at Motilal Oswal, said the weakness could continue and the stock could drift down to Rs 3,950.
Market Wrap: Consumer stocks drag D-Street lower; Sensex sheds 312 pts, Nifty below 23,700
Indian benchmarks indices ended lower on Wednesday, as advances in heavyweight financials and oil and gas firms were offset by losses in consumer stocks. Investors
February 5, 2025